Transparency of EU medicines agencies
Kopp, C.
Prescrire International 12(66): 156
2003
ISSN/ISBN: 1167-7422 PMID: 12908499 Document Number: 556523
Document emailed within 1 workday
Related Documents
Stander, M.Petrus.; Bergh, M.; Miller-Jansön, H.Elizabeth. 2013: A first step towards transparency in pricing of medicines and scheduled substances - publication of guidelines for pharmaco-economic submissions South African Medical Journal 104(1): 10-11Pijpers, E.L.; Kreijkamp-Kaspers, S.; McGuire, T.M.; Deckx, L.; Brodribb, W.; van Driel, M.L. 2017: Women's questions about medicines in pregnancy - An analysis of calls to an Australian national medicines call centre Australian and New Zealand Journal of Obstetrics and Gynaecology 57(3): 334-341
Orubu, E.Samuel.F.; Okwelogu, C.; Opanuga, O.; Nunn, T.; Tuleu, C. 2016: Access to age-appropriate essential medicines: a retrospective survey of compounding of medicines for children in hospitals in Nigeria and implications for policy development Health Policy and Planning (): -
Bamberger, L. 1966: Project planning and development by official health agencies. I. Opportunities for official health agencies in the community action program American Journal of Public Health and the Nation's Health 56(4): 596-599
Coghlan, R.; Stephens, P.; Mwale, B.; Siyanga, M. 2018: A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia Malaria Journal 17(1): 444
Beer, A.M.; Schilcher, H.; Loew, D. 2013: Herbal medicines alternative to synthetical medicines MMW Fortschritte der Medizin 155(Suppl 4): 97-99
Gini, J.; Amara, A.; Penchala, S.D.; Back, D.J.; Else, L.; Egan, D.; Chiong, J.; Harri, B.I.; Kabilis, E.D.; Pama, P.P.; Stephen, M.; Khoo, S.H. 2019: Widespread use of herbal medicines by people living with human immunodeficiency virus and contamination of herbal medicines with antiretrovirals in Nigeria International Journal of Std and Aids 30(4): 371-377
Wang, H.; Zhang, X-Bo.; Huang, L-Qi.; Guo, L-Ping.; Wang, L.; Zhao, Y-Ping.; Yang, G. 2017: Design and implementation of supply security monitoring and analysis system for Chinese patent medicines supply in national essential medicines Zhongguo Zhong Yao Za Zhi 42(22): 4310-4313
Joshua, I.B.; Passmore, P.R.; Sunderland, B.V. 2016: An evaluation of the Essential Medicines List, Standard Treatment Guidelines and prescribing restrictions, as an integrated strategy to enhance quality, efficacy and safety of and improve access to essential medicines in Papua New Guinea Health Policy and Planning 31(4): 538-546
Dennis, D. 2008: Transparency Bulletin of the American College of Surgeons 93(12): 45
Kiefer, B. 2007: Transparency and obscurity Revue Medicale Suisse 3(97): 376
Nossen, J. 1979: Transparency list. MMW 121 (1979) 81, 125 Münchener Medizinische Wochenschrift 121(15): 499-500
Bock, C. 2014: Transparency creates trust Pflege Zeitschrift 67(8): 462-465
Levin, A. 2001: Reporting standards and the transparency of trials Annals of Internal Medicine 134(2): 169-172
Dölle, W. 1979: Transparency list--a final word Münchener Medizinische Wochenschrift 121(12): 400-401
Nau, J.-Y. 2011: AIDS, tuberculosis, malaria, transparency Revue Medicale Suisse 7(287): 674-675
Smith, J. 2013: Buyers should demand price transparency Modern Healthcare 43(48): 34
Carroll, J. 2013: No informed consumers without price transparency Managed Care 22(10): 17-18
Sipkoff, M. 2004: Can transparency save health care? Managed Care 13(3): 28-32
Mizumachi, S.; Kojima, S.; Nakamura, A. 1989: Transparency test for plastic containers Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 107: 94-99